Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-23

Clinical Trial Update: Sequential Study to Treat Renal Cell Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial for renal cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sponsor GmbH | Conditions: Renal Cell Carcinoma | Phase 3 | Status: COMPLETED